Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1974 | 1974 | |||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 2018 | 2020 | ||||||||
|
alkaline phosphatase, placental | 0.487 | 0.808 | 1.8E-13 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2020 | ||||||||
|
amphiregulin | 0.487 | 0.769 | 0.35 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
angiotensin I converting enzyme 2 | 0.477 | 0.769 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
annexin A11 | 0.650 | 0.692 | 4.7E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
annexin A2 | 0.453 | 0.808 | 9.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1997 | 2001 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
aquaporin 4 | 0.456 | 0.885 | 2.3E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
argonaute RISC catalytic component 2 | 0.501 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
asparaginase and isoaspartyl peptidase 1 | 0.494 | 0.808 | 2.8E-05 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2020 | ||||||||
|
AT-rich interaction domain 3A | 0.678 | 0.500 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2020 | |||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.030 | None | 0.667 | 3 | 1 | 2003 | 2006 | ||||||||
|
ATP binding cassette subfamily B member 11 | 0.566 | 0.654 | 1.6E-12 |
|
disease | 0.040 | None | 0.750 | 4 | 2 | 2003 | 2014 | ||||||||
|
ATP binding cassette subfamily B member 4 | 0.529 | 0.615 | 2.2E-07 |
|
disease | 0.390 | None | 0.818 | 11 | 2 | 1997 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.520 | None | 1.000 | 4 | 0 | 2003 | 2005 |